share_log

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $28 Price Target

Benzinga ·  Oct 11, 2023 07:46

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment